Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Share Buyback Programme Cancellation

3 Mar 2025 07:01

RNS Number : 9841Y
Severfield PLC
03 March 2025
 

March 2025

Severfield plc

('Severfield' or 'the Company')

Share buyback programme cancellation

 

As noted in this morning's trading update announcement, Severfield plc, the market-leading structural steel group, announces that, with effect from 3 March 2025, it has terminated the agreement entered into with Liberum in respect of £10m share buyback programme announced on 17 April 2024 thereby cancelling the buyback programme.

 

In aggregate, between 17 April 2024 and 28 February 2025, the Company repurchased and cancelled 13,356,334 ordinary shares at a cost of £9,262,581 (excluding stamp duty and expenses).

 

Severfield's current issued share capital is 296,181,987 ordinary shares. Accordingly, the total number of voting rights in Severfield as at 28 February 2025 is 296,181,987. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

Severfield Alan Dunsmore 01845 577 896

Chief Executive Officer

 

Adam Semple 01845 577 896

Chief Financial Officer

 

Jefferies International Will Soutar 020 7029 8000

 

Panmure Liberum Nicholas How 020 3100 2000

 

Camarco severfield@camarco.co.uk

Ginny Pulbrook 07961 315 138

Tom Huddart 07967 521 573

 

Notes:

Except as otherwise stated '2025 and FY25', '2026 and FY26' and '2027 and FY27' refer to the 52-week periods ending 29 March 2025, 28 March 2026 and 27 March 2027. The Group's accounts are made up to an appropriate weekend date around 31 March each year.

 

Notes to editors:

Severfield is the UK's market leader in the design, fabrication and construction of structural steel, with a total capacity of c.150,000 tonnes of steel per annum. The Group has seven sites, c.1,900 employees and expertise in large, complex projects across a broad range of sectors. The Group also has an established presence in the expanding Indian market through its joint venture partnership with JSW Steel (India's largest steel producer).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJTMFTMTAMBBA
Date   Source Headline
23rd Nov 20217:00 amRNSInterim Results
9th Nov 202112:53 pmRNSIssue of Ordinary Shares
29th Oct 202112:55 pmRNSIssue of Ordinary Shares
19th Oct 20212:30 pmRNSDirector/PDMR Shareholding
13th Oct 20214:35 pmRNSPrice Monitoring Extension
13th Oct 202111:30 amRNSDirector/PDMR Shareholding - AMENDED
12th Oct 20215:43 pmRNSDirector/PDMR Shareholding
12th Oct 202110:45 amRNSIssue of Ordinary Shares
5th Oct 202112:47 pmRNSDirector/PDMR Shareholding
4th Oct 20214:08 pmRNSDirector/PDMR Shareholding
29th Sep 202112:39 pmRNSIssue of Ordinary Shares
28th Sep 20215:56 pmRNSDirector/PDMR Shareholding
21st Sep 202111:16 amRNSIssue of Ordinary Shares
20th Sep 20213:39 pmRNSDirector/PDMR Shareholding
17th Sep 202111:28 amRNSDirector / PDMR Shareholding
14th Sep 202111:45 amRNSIssue of Ordinary Shares
14th Sep 20218:00 amRNSEdison Investment Research Limited: Applied Graphene Materials (AGM): Initiation - Delivering the potential of graphene
13th Sep 20217:00 amEQSSeverfield (SFR): Positive start to FY22
7th Sep 202111:52 amRNSIssue of Ordinary Shares
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 202111:48 amRNSResults of Annual General Meeting 2021
1st Sep 20217:00 amRNSAGM Trading Update
24th Aug 20219:05 amRNSDirector/PDMR Shareholding
4th Aug 20214:27 pmRNSDirector/PDMR Shareholding
2nd Aug 20219:45 amRNSNotice of AGM
26th Jul 20213:21 pmRNSDirector/PDMR Shareholding
19th Jul 202112:42 pmRNSDirector/PDMR Shareholding
1st Jul 202112:07 pmRNSAdditional Listing of Shares
30th Jun 20213:32 pmRNSDirector/PDMR Shareholding
28th Jun 20215:20 pmRNSDirector/PDMR Shareholding
21st Jun 20214:03 pmRNSDirector/PDMR Shareholding Correction
18th Jun 20217:52 amRNSDividend Correction
18th Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 202111:52 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSProgressive publishes new research
16th Jun 20217:00 amRNSResults for the Year Ended 31 March 2021
18th May 20214:24 pmRNSDirector/PDMR Shareholding
11th May 20213:21 pmRNSIssue of Ordinary Shares
23rd Apr 202110:49 amRNSDirector/PDMR Shareholding
22nd Apr 202110:52 amRNSBlock listing Six Monthly Return
22nd Apr 202110:09 amRNSProgressive publishes new research
22nd Apr 20217:00 amRNSPre-Close Trading Update
21st Apr 20214:27 pmRNSHolding(s) in Company
17th Mar 202112:30 pmRNSDirector/PDMR Shareholding
16th Mar 202111:25 amRNSIssue of Ordinary Shares
3rd Mar 202111:20 amRNSIssue of Ordinary Shares
3rd Mar 202111:18 amRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSAcquisition of DAM Structures Limited
17th Feb 202111:54 amRNSDirector/PDMR Shareholding
16th Feb 202112:06 pmRNSIssue of Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.